Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma. - Bjorklund CC; Larrayoz M; Kang J; Chiu H; Shtraizent N; Wu L; Li S; Hsu CC; Zhao J; Amatangelo M; Chow TT; Wollerman K; et al. (Blood neoplasia, 2025)